Compare COCH & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | COCH | COHN |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | United States |
| Employees | 47 | N/A |
| Industry | Blank Checks | Investment Bankers/Brokers/Service |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 54.3M |
| IPO Year | N/A | 2003 |
| Metric | COCH | COHN |
|---|---|---|
| Price | $0.64 | $12.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 117.1K | 32.6K |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.35% |
| EPS Growth | N/A | ★ 5537.50 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $275,564,000.00 |
| Revenue This Year | $1.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.92 |
| Revenue Growth | N/A | ★ 246.19 |
| 52 Week Low | $0.36 | $7.78 |
| 52 Week High | $1.91 | $32.60 |
| Indicator | COCH | COHN |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 30.02 |
| Support Level | $0.63 | $10.32 |
| Resistance Level | $0.73 | $12.33 |
| Average True Range (ATR) | 0.04 | 1.76 |
| MACD | -0.00 | -1.21 |
| Stochastic Oscillator | 15.98 | 1.81 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.